Serum antioxidant vitamin levels in patients with coronary heart disease

Hilal Yıldıran1, Seyit Mehmet Mercanlıgil, Halit Tanju Besler

  • 1Gazi University, Faculty of Health Sciences, Department of Nutrition and Dietetics, Besevler, Ankara, Turkey. ciftcihilal@hotmail.com

Insights

Men with coronary heart disease (CHD) exhibit higher fat mass and lower serum antioxidant vitamin levels. These factors, along with lower high-density lipoprotein cholesterol (HDL-C), may indicate increased CHD risk.

Area of Science:

  • Cardiology
  • Nutritional Science
  • Human Physiology

Background:

  • Coronary heart disease (CHD) is a leading cause of mortality.
  • Understanding risk factors beyond traditional markers is crucial for prevention and management.

Purpose of the Study:

  • To investigate anthropometric measurements, body composition, and serum antioxidant vitamin levels in men with CHD.
  • To compare these parameters between men with and without CHD.

Main Methods:

  • Cross-sectional study comparing 35 men with CHD and 31 men without CHD (aged 40-65).
  • Data collection included dietary records, anthropometric measurements, and analysis of serum antioxidant vitamins and lipid profiles.

Main Results:

  • Men with CHD had significantly higher fat mass (FM) and fat mass percentage (FM%).
  • Lower high-density lipoprotein cholesterol (HDL-C) levels were observed in men with CHD.
  • Serum levels of vitamins A, E, and C were significantly lower in men with CHD compared to controls.

Conclusions:

  • Elevated fat mass, reduced HDL-C, and lower serum antioxidant vitamin levels are potential risk factors for coronary heart disease.
  • These findings suggest a role for body composition and micronutrient status in CHD pathogenesis.

Related Concept Videos

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
Blood Studies for Cardiovascular System III: Serum Lipid Profile01:25

Blood Studies for Cardiovascular System III: Serum Lipid Profile

Understanding serum lipids is crucial for maintaining cardiovascular health and preventing heart disease and stroke.
Serum lipids are fats and fatty substances in the blood and are crucial for various bodily functions, including energy storage, cellular structure, and hormone production. Serum lipids consist of cholesterol, triglycerides, and phospholipids.
Cholesterol is a soft, fat-like substance found in all body cells. It is crucial for producing hormones, vitamin D, and substances that aid...
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
Coronary Artery Disease III: Clinical Manifestations01:30

Coronary Artery Disease III: Clinical Manifestations

Coronary Artery Disease (CAD) is a primary health risk worldwide, leading to significant morbidity and mortality. The condition arises from the buildup of atherosclerotic plaques within the coronary arteries, resulting in diminished blood supply to the heart muscle.The clinical manifestations of CAD vary widely, from asymptomatic stages to severe, life-threatening conditions. Understanding these manifestations is crucial for early diagnosis and effective management.Angina Pectoris: The Warning...